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1. Introduction 
Neuropeptide- glutamic acid isoleucine (NEI) is a peptide related to reproduction. Although 
it also has an important function on behavior [2-6], we will focus here on the relationship 
between NEI and LH. 
NEI is derived from the precursor pre- prohormone named pp melanin-concentrating 
hormone (pp-MCH). This precursor also gives rise to melanin concentrating hormone 
(MCH) and to neuropeptide-glycine-glutamic acid (NGE) [7-9].  
Some studies have suggested a role of NGE at the level of the hypothalamus. For instance, 
NGE increases the number of neurofilaments and the production of synaptophysin in rat 
neurons within 18 days of development [10-12]. 
Immunoreactivity and mRNA expression of both MCH and NEI have been observed in 
certain regions of the central nervous system. The first region is the diencephalon including 
the rostralmedial part of the zona incerta, later refer to as the incerto-hypothalamic area 
(Ihy) by Sita et al. [13]; the three subdivisions (anterior, tuberal and posterior) of the lateral 
hypothalamus (LHA); the area between the dorsomedial and ventromedial nuclei of the 
hypothalamus, which Swanson [14] designated as the internuclear area, the anterior 
periventricular nucleus; and the dorso medial aspects of the tuberomammillary complex. 
The second region includes the olfatory tubercle, located in the basal forebrain. The third 
region includes the paramedian pontine reticular formation in the pons [7]. It is important to 
note that the highest concentration of MCH/NEI ir cells is found in the Ihy and the LHA. We 
found nearly all the cells in these two regions were immureactive for both MCH and NEI 
(mean +-S.E.M, 96 +-3%) (Fig.1 and 2) 
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Figure 1. Diencephalic distribution of NEI-immunoreactivity-containing cells. Brightfield 
photomicrographs of immunoperoxidase material stained for NEI-ir. (A) NEI-ir-containing cells in the 
incerto-hypothalamic area. (B) NEI-ircontaining cells in the lateral hypothalamic area. Abbreviations: 
mt, mammilothalamic tract; bv, blood vessels; IHy, incerto hypothalamic area; 3v, third ventricle; ic, 
internal capsule; LHA, lateral hypothalamic area; f, fornix. Bar = 200 mm. - Reproduced from 
Bittencourt and Celis, 2008, with permission from Peptides (29:1441-50). 
 
 
Figure 2. Deduced structure of rat prepro-MCH. The relative positions of the amino (NH2) terminal 
signal peptide (SP), and the putative MCH, NEI and NGE sequences at the carboxy (COOH) terminus 
are indicated. The amino acids sequence of NEI is expanded below it. The putative proteolitic 
processing sites are marked with arrowheads. - Reproduced from Bittencourt and Celis, 2008, with 
permission from Peptides (29:1441-50). 
Peptides such as NGE, NEI and MCH are highly conserved among vertebrates, being 
abundant and widely distributed in the brain, suggesting that they could be performing 
important physiological functions. NEI is a 13 aminoacid peptide and has an extensive 
distribution in the central nervous system (CNS), acting as a neurotransmitter or 
neuromodulator [15-17]. Neurotranmitter NEI induces grooming behavior, locomotor 
activity, and stimulates sexual receptivity in female rats [1-6]. NEI injections can modify the 
levels of noradrenaline and dopamine in specific areas of the brain [4], and earlier studies 
demonstrated that MCH injection into the preoptic area or median eminence induces 
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luteinizing hormone (LH) secretion. Subsequent studies have shown that modified 
circulating hormonal levels might modulate ppMCH neurons [18] It has been reported that 
treatment with 17β-estradiol increases MCH and NEI immunoreactivity throughout the 
entire diencephalon of ovariectomized cynomologous monkeys [18]. Similar effects were 
observed in ovariectomized rats receiving no gonadal estradiol treatment [19]. Levels of 
ppMCH mRNA are only increased in the medial zone incerta (ZI) [15], which houses the 
A13 group, a collection of dopaminergic neurons that have been previously demonstrated to 
play a stimulating role in gonadotropin release [20]. 
More recently, various studies have explored the potential mechanisms by which MCH 
induces LH secretion [21-27]. Surprisingly, few have examined the role played by NEI in 
this process. 
2. Ovarian steroids effects 
Viale et al (1999) proposed a central role of the MCH/NEI neuronal system in the regulation 
of reproductive functions in rats [18]. In fact, the MCH/NEI system of immunoreactive fibers 
and terminals that is encountered in hypothalamic areas such as the medial preoptic area 
(MPOA), is well known to be involved in the control of pre-ovulatory LH surge. These 
authors studied the effects of the treatment with estrogen on the immunoreactivity of NEI 
and MCH in OVX animals, using the non-human primate (M. Fasscicularis). A slight increase 
of MCH-IR after 30 days post treatment with estrogen, along with a concurrent significant 
rise in NEI-IR was observed. A three-fold increase in MCH and NEI –Ir was seen at 72 h 
post estrogen treatment, compared with the amount of both peptides-ir at 48h post 
treatment. These facts suggest the possible involvement of these peptides in the regulation 
of the pre-ovulatory mid- cycle LH surge in primates [19]. 
The MCH receptors are classified into five subtypes: MC1-R to MC5-R [28]. MCH stimulates 
gonadotropin-releasing hormone (GnRH) release from hypothalamic explants, and it is 
interesting to note that MCH affects the release of LH [23] in the female rat. When MCH was 
injected bilaterally into the rostral preoptic area (rPOA) or medial preoptic area (mPOA) of 
estrogen-primed ovariectomized rats, LH release was stimulated. Two MCH receptors are 
involved in the MCH effect. The stimulatory action of MCH in the rPOA was inhibited by 
administration of antagonists for either MC-1 R or MC-5R, indicating that both ones, MC-1R 
and MC-5 are involved in the central control of GnRH release by MCH [19-27]. 
3. The effect of neuropeptide EI on LH regulation 
For this study we used male and female rats, aged 10-14 weeks which were bred in our 
laboratory and maintained with food and water ad libitum, with a cycle of 14h/ light/10h 
dark and a temperature controlled environment (22±2ºC). The animal procedures were 
consistent with the standards established by the National Institutes of Health Guide for the 
Care and Use of Laboratory Animals (1996) and the AmericanVeterinarian Guidelines of 
Eutanasia. 
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The first evidence, on the effects of NEI on LH regulation was provided by Attademo et al 
[1], using male and ovariectomized rats treated with estrogen benzoate (10 ug) and low 
doses of progesterone (40ug). These animals revealed the following: when male rats were 
treated with intraventricular injections of NEI (1ug/1ul), the peptide induced an increase of 
serum LH concentration throughout the entire period studied (10-90 min). At 90 min the 
serum LH slightly decreased, possibly signaling initiation of the recovery of normal LH 
serum levels. Control rats injected with artificial cerebrospinal fluid showed practically no 
changes on serum LH concentrations (Fig. 3). It was also possible to see the NEI effect on 
ovariectomized female rats treated with estrogen plus progesterone, by using a low dose of 
progesterone to permit the visualization of modifications in the LH surge. Again, the 
neuropeptide increased LH release compared with control animals (Fig.4)  
The fact that the effect of NEI may be mediated by the noradrenergic system must be taken 
into consideration. The peptide is known to modify DA and NA in the nucleus accumbens 
and caudate putamen during grooming behavior and locomotion activity [4]. As NEI 
behaves similarly to α-MSH, it is important to note that there is some relation between 
MCH-NEI and α-MSH, indicating that all three peptides are associated in a complex inter-
relationship [1]. 
 
 
 
Figure 3. Effect of icv administration of NEI or ACSF (controls) on plasma LH concentration in male 
rats. Blood samples were collected at 0 (before NEI or ACSF injection), 10, 30, 60 and 90 min post-
injection. Bars represent the mean ± S.E.M. ∗P < 0.05 compared to controls. - Reproduced from 
Attademo et al, 2004, with permission from Peptides. 
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Figure 4. Time course of LH release in CHR-OVX-EB-progesterone treated female rats in the presence 
(◦) or absence () of NEI. CHR-OVX rats were subcutaneously injected with 10 ug EB and 3 days later 
with 40 ug progesterone at 13:00 h. On the same day of the progesterone injection, the animals were 
injected icv 1 ug/ul of NEI or ASCF (controls) at 12:00 and 14:00 h. Blood samples were obtained 
between 15:00 and 21:00 h via the jugular vein, and the plasma levels of LH were measured. The plotted 
values represent the mean ± S.E.M. (n = 6). ∗P < 0.05 compared to controls. - Reproduced from Attademo 
et al, 2004, with permission from Peptides. 
4. Distribution of NEI immunoreactivity  
In this study, we described the anatomical substrate underlying the NEI effect of inducing 
LH secretion, using techniques of double and triple label immunohitochemistry, as well as 
dual label immunofluorescence. A group of female rats were perfused on day 15 
postovariectomy; a second group received10 µg of estradiol benzoate and were perfused 
two days later and a third group received 10 µg of estradiol benzoate and two days later 40 
µg of progesterone and were perfused 5 h after treatment. To mimic the manipulation of the 
animals, we used a fourth group of ovariectomized rats treated with sesame oil, and also 
used female intact rats at proestrus and diestrus [28]. 
Using these techniques, we were able to obtain the following results: 
NEI-ir neurons were observed in the medial ZI, in the perifornix at the tuberal hypothalamic 
level and in the lateral hypothalamus. Fibers were distributed throughout the forebrain, 
including areas related to reproductive control and LH secretion. We observed a dense 
number of NEI-ir fibers in the medial septal nucleus, the diagonal band of Broca, the environs 
of OVLT, the preoptic area and in the internal layer of the median eminence (Fig. 5). 
All fibers seen in these areas show varicosities and terminal-like structures. NEI and 
terminal-like structures were in close apposition with portal blood vessels and GnRH 
neurons expressing Fos (Fig. 6 A and B) 
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Figure 5. Distribution of NEI-ir fibers in forebrain areas related to reproduction. Bright-field 
photomicrographs of reference sections with thionine staining showing the OVLT ( A ) and AVPV ( C ). 
Dark-field photomicrographs showing the distribution of NEI-ir fibers in the environs of the OVLT ( B ) 
and in the AVPV ( D ). E Bright-field photomicrograph showing the distribution of NEI-ir fibers in the 
median eminence (ME). F Dark-field photomicrograph of the same section showing the distribution of 
NEIir fibers in the ME. MEi = Internal layer of the median eminence; MEe = external layer of the median 
eminence; ox = optic chiasm; 3v = third ventricle; ac = anterior commissure; DB = nucleus of the diagonal 
band; MPO = medial preoptic nucleus; MS = medial septal nucleus. Scale bar: 400 µm ( A–D ), 200 µm ( 
E , F ). - Reproduced from Attademo et al, 2006, with permission from Neuroendocrinology. 
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Figure 6. Alternative pathways for NEI induction of LH secretion. A , B Bright-field photomicrographs 
showing NEI-ir varicosities and terminal-like structures in the median eminence (ME). Note the close 
proximity to blood vessels (arrows). C Bright-field photomicrograph showing NEI-ir varicosities in 
close apposition with AVPV neurons expressing Fos (Fos-ir) in the afternoon of the proestrus day 
(arrows). D Bright-field photomicrograph showing NEI-ir fibers in close apposition with GnRH-ir 
neurons expressing Fos in the afternoon of the proestrus day (arrows). E Bright-field photomicrograph 
showing NEI-ir varicosities (in black) in close apposition with GnRH-ir fibers (in light brown) in the 
ME. F Fluorescence photomicrograph showing the close association between NEI-ir (in green, 
AlexaFluor 488) and TH-immunoreactive (TH-ir, in red, AlexaFluor 594) neurons in the medial zona 
incerta (ZIm). G Fluorescence photomicrograph showing TH-ir fibers in close apposition with NEI-ir 
neurons in the ZIm (arrow). v = Blood vessel; MPO = medial preoptic nucleus. Scale bar: 50 µm ( A–E , 
G ); 100 µm ( F ). - Reproduced from Attademo et al, 2006, with permission from Neuroendocrinology. 
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5. NEI-ir fibers innervate GnRH and AVPV neurons expresing fos 
We observed an increased expression of Fos immunoreactivity in the anteroventral 
periventricular nucleus (AVPV) neurons of rats perfused during the afternoon of the day of 
proestrus, as well as in ovariectomized rats treated with estradiol benzoate plus 
progesterone, as described by others [30, 31]. Close to a 10% of the AVPV neurons 
expressing Fos receive NEI fibers in close apposition. Very little Fos immunoreactivity was 
observed in rats perfused in the afternoon of the diestrus day, for either of the following 
conditions: ovariectomized treated with estradiol benzoate or ovariectomized treated with 
sesame oil. In addition, all groups, showed a sparse distribution of Fos immunoreactivity in 
the medial zone incerta and in the LHA, whereas co-localization of NEI fibers with any of 
these cells was not observed (Fig. 6 D). 
It has been reported that Fos protein is expressed in a portion of GnRH neurons that are active 
in the afternoon of the proestrus day, as well as in the GnRH neurons of ovariectomized rats 
treated with estradiol benzoate plus progesterone [31-33]. Based on these results, we 
investigated the pattern of NEI innervations in areas that expressed GnRH neurons in these 
animals. Most of the neurons expressing Fos were found to be in the vicinity of the organum 
vasculosum of the lamina terminalis (OVLT) and of the preoptic area. NEI fibers were also 
found in the median eminence, and NEI and GnRH varicosities presented similar distribution, 
thus revealing close apposition between them. Immediately before and during LH surge (on 
the afternoon of the proestrus day or following treatment with estrogen plus progesterone), 
only a portion of the GnRH neurons expressed Fos [30,31,33,34-36].  
AVPV, is a nucleus that also expresses Fos in the afternoon of the proestrus day and has 
been widely implicated in the control of reproduction [32], with Fos expression indicating 
neuronal response [36]. However, in rats perfused on the diestrus day or in ovariectomized 
rats receiving estradiol benzoate or sesame oil, we did not find Fos expression in GnRH 
neurons. The pattern of distribution of NEI-ir and GnRH ir in the median eminence, showed 
NEI fibers to be denser in the internal layer than in the external one. Nevertheless, in the 
external layer, NEI and GnRH varicosities presented similar distributions, revealing an 
apparent close apposition between them. In the present study, we labeled distinctive cell 
compartments by using dual and triple-label immunohistochemistry which revealed NEI-ir 
fibers to be innervating the Fos-positive neurons in the AVPV, as well as the GnRH neurons 
positive for Fos immunoreactivity. In these experiments we labeled distinct cell compartments 
(cytoplasm, nuclei and terminals) using various antisera, all raised in rabbit. In the control 
tests, the second or third antisera were omitted, and no reaction was evident. This indicates 
that the observed labeling of cell bodies, fibers or both was not the result of cross-reactivity of 
the secondary antibody. In addition, evaluation of the data under light microscopy at a high 
magnification revealed only a suggestion of synaptic contact (Fig 6 A-B). 
6. NEI innervation of GnRH neurons 
Our results indicated that NEI fibers were in close apposition with GnRH neurons 
expressing Fos in the afternoon of the proestrus day. Since Fos protein expression in GnRH 
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neurons increases in parallel with rises in the plasma LH levels [27, 31, 32], it can be 
assumed that these neurons project to the median eminence and induce LH secretion during 
proestrus. Therefore, we can suggest that NEI (through projections to a subset of GnRH 
neurons) modulated GnRH activity and, consequently, LH surges.  
The role that NEI plays in GnRH secretion has not been investigated. However, NEI 
varicosities in some parts of the median eminence display a pattern of distribution similar to 
that of GnRH, revealing a possible effect on the modulation of GnRH secretion directly at 
the terminals. This may represent one of the mechanisms by which intracerebroventricular 
administration of NEI causes an increase in LH secretion (Fig. 6 E) 
Experiments using in vitro preparations or intracerebroventricular injections have shown 
that various neurotransmitters can regulate gonadotropin release [38-40]. One such 
neurotransmitters is the cocaine- and amphetamine- regulated transcript (CART) peptide, 
which has been shown to increase the GnRH pulse amplitude in cycling female rats and to 
decrease GnRH pulse intervals in prepubertal rats [41-43]. These effects can be achieved 
through direct CART innervation of the GnRH neurons [39, 40]. Interestingly, in the medial 
ZI and lateral hypothalamus, MCH/NEI neurons coexpress CART [44, 46]. In the present 
study, we did not explore the origins of NEI innervation of GnRH neurons or areas related 
to reproductive behavior. However, it is intriguing that the number of NEI-ir neurons in 
ovariectomized rats was increased only in the medial ZI, a brain region that projects to the 
AVPV and GnRH- containing areas [47,48], as well as to the circumventricular organs, 
probably including the median eminence [44, 45]. This result is in agreement with those of 
other studies in which ppMCH mRNA expression was found to be greater in the medial ZI 
of untreated ovariectomized rats than in that of ovariectomized rats primed with estradiol 
benzoate or estradiol benzoate plus progesterone.  
7. In vitro studies 
Taken into account the above results, we decided to investigate whether NEI could act directly 
at the pituitary level by modulating hormone secretion. With this purpose the effects of NEI 
were studied in pituitary cell cultures from female rats on the release of several pituitary 
hormones (GH, LH and prolactin). Furthermore, the ability of NEI to activate pituitary cells 
was evaluated by electron microscopy and immunocitochemistry [49], and finally, the ability 
of NEI to potentiate GnRH-induced LH release was tested. The study of the effects of 
physiological stimuli involved in the regulation of pituitary hormone secretion was facilitated 
by the availability of a system consisting of a suspension of single dispersed pituitary cells, in 
which the cell functions were essentially the same as in situ [50]. For this study we used female 
rats in order to obtain a primary culture. The results were as follows: 
NEI induced a fast release of LH in the culture cell media. In addition, there were 
differences in the LH levels obtained for the various time periods of hormonal stimuli 
assayed, which were closely associated with the doses applied. The lowest dose of NEI (100x 
10-8M) induced a significant increase of LH secretion after 2h of stimulus, achieving 
maximum response after 4h of NEI treatment. At this time, the LH levels almost reached a 
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five-fold increase over controls and then maintained these values (Fig.7). In spite of NEI 
being effective in stimulating LH secretion, none of the assayed doses were capable of 
significantly promoting FSH secretion from gonadotrophs. In addition, no significant 
increases were observed on prolactin or GH secretion, at doses ranging from 100x10-8 to 
400x10-8 M NEI in primary cell cultures, thus confirming the specificity of NEI stimuli on LH 
secretion (Table 1). To determine whether or not NEI was able to synergize with GnRH in 
stimulating LH release, pituitary cells were simultaneously incubated with GnRH (0.1 or 
1x10-9M) and different concentrations of NEI (1, 10 or 100x10-8M) for 3 h and then the media 
was collected and tested for LH by RIA (Fig. 8). Although NEI at the dose of 10x10-8M had 
no effect on LH secretion, GnRH 1x10-9M plus NEI 10x10-8M induced a slight but significant 
increase in LH concentrations (16%; p< 0.01). A combined treatment with the highest doses 
of both NEI and GnRH significantly stimulated the secretory response, which was more 
effective than that observed with the same dose of GnRH alone [49] (Fig.8).  
When pituitary cells from female rats were cultured, different types of secretory cells were 
observed (Fig. 9). These were identifiable by their ultra structural characteristics, essentially 
by the profile of the secretory granules, which constituted a distinctive feature. The most 
frequent populations observed were lactotroph and somatotroph cells, which were in close 
contact with gonadotrph cells. In the control group, the lactotroph and somatotroph cells 
have numerous polymorphic and round mature secretory granules respectively. These also 
had high electron densities and were stored in the cytoplasm. The gonadotroph were 
 
Figure 7. Time-course study of the effects of NEI on LH secretion in the culture media. The cell cultures 
were treated with NEI 100 or 400 x 10-8 M for 1–5 h, in serum free conditions. The data are represented as 
mean ± S.E.M. of three independent experiments. Data were evaluated by the ANOVA–Fisher test; *p < 
0.01 vs Control group. – Reproduced from De Paul et al, 2009, with permission from Peptides. 
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Table 1. Time-course study of the effects of NEI on FSH, PRL and GH secretion accumulated in the 
culture media (ng/ml of culture medium). Pituitary cells were treated with NEI 100 or 400×10-8M for 1–5 
h. The data are shown as the mean ±S.E.M. of three independent experiments and were evaluated by 
the ANOVA–Fisher test. 
 
Figure 8. NEI and GnRH combined treatments on LH secretion. The presence of 10 and 100 x 10-8 M 
NEI in the culture media for 3 h promoted a significant increase in LH release stimulated by GnRH 1 
x10-9 M. Data are shown as the mean ± S.E.M. of three independent experiments. ANOVA–Fisher test; 
*p < 0.01 vs control group; **p < 0.01 vs GnRH 1 x 10-9 M. – Reproduced from De Paul et al, 2009, with 
permission from Peptides. 
characterized by a conspicuous accumulation of round secretory granules of two different 
sizes and by electron densities in the cytoplasm. The most abundant granules were about 
150nm in diameter and filled with homogenous material, whereas the others less frequent 
but larger in size (about 400nm) (Fig. 10 A and B).Stimulation with NEI (100 x 10-8 and 400 
x 10 -8) for 2 and 4 hour, promoted several subtle structural changes, particularly in the  
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Figure 9. (A) Electron micrograph of a pituitary cell culture from control rats illustrating different 
pituitary cell populations. Two lactotroph cells (L) exhibit an accumulation of large and polymorphic 
mature secretory granules (about 500– 900 nm in diameter) in the cytoplasm. The somatotroph cell (S) 
can be easily recognized by the mature, round GH secretory granules ranging from 200 to 350 nm in 
diameter and scattered throughout the cytoplasm. In close contact with both secretory cell types, a 
gonadotroph cell (G) displays small (ssg) and large (lsg) round secretory granules (about 150 or 400 nm 
in diameter respectively, with different electron densities, homogeneously disseminated in the 
cytoplasm (m = mitochondria, N = nucleus). Bar: 1 µm. (B) Gonadotroph cell specifically 
immunostained for LH. The cytoplasm shows a noticeable accumulation of characteristic small (ssg) 
and large (lsg) round secretory granules (m = mitochondria, N = nucleus). Bar: 0.5 µm. – Reproduced 
from De Paul et al, 2009, with permission from Peptides. 
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Figure 10. (A) Electron microscopy of two cultured gonadotroph cells treated with 400 x 10-8 M NEI for 
4 h. The cytoplasm contains a remarkably well developed rough endoplasmic reticulum (RER) and 
Golgi complex (GC) and also scarce small secretory granules (ssg) that are mostly in contact with the 
plasma membrane. Bar: 0.5 µm. (B) Electron micrograph of a cultured gonadotroph cell (G) after 
exposition to 100 x 10-8 M NEI for 2 h which is shown exhibiting small secretory granules (ssg) 
mobilized toward the plasmalemma, where they will then be subsequently discharged by exocytosis. 
Bar: 0.5 mm. Inset: small round secretory granules from a gonadotroph cell specifically identified by 
immunocytochemistry for LH. Bar: 0.5 mm. (C) Detail of two adjacent gonadotroph cells after NEI 
treatment displaying evidence of secretory activity. The secretory granules are aligned alongside the cell 
membrane and are in the process of exocytosis (arrows). Bar: 0.5 µm. – Reproduced from De Paul et al, 
2009, with permission from Peptides. 
 
Gonadotropin 102 
gonadotroph cell population. For this cell type, the most prominent changes consisted of a 
striking development of the rough endoplasmic reticulum (RER) and Golgi complex (Fig 
10B) when compared to the control group. Many secretory granules were located to the 
cell membrane and presented images of exocytosis after NEI treatment (Fig. 10 C) Other 
pituitary cell populations, the lactotrophs, thyrotrophs and somatotrophs, did not exhibit 
any features indicating a significant activation of hormone release after NEI treatment. 
The present results were the first demonstration of a specific and direct action of NEI in 
cultured pituitary cells without modifying other pituitary hormones. Moreover, the analysis 
of the electron microscope images taken 2 and 4h after NEI treatment was indicative of the 
stimulation of LH release occurring at these times. 
From the present study, it is possible to conclude that NEI is effective when injected into the 
brain to release LH in male and female rats. The anatomical substrate underlying this effect 
was identified using combined methods of immunohistochemistry. A schematic 
representation of the proposed pathways by which NEI participates in LH secretion is 
depicted in Figure 11.  
NEI is also capable of inducing a marked release of LH without modifying the other 
pituitary hormones in the pituitary cultured cells. There is an interaction between NEI and 
GnRH in vivo and in vitro. 
 
 
Figure 11. Schematic representation of the proposed pathways by which NEI participates in LH 
secretion. NEI-ir neurons in the medial zona incerta (ZIm) or LHA receive dopaminergic innervation 
from TH neurons located in the ZIm and project directly to the median eminence or to GnRH neurons 
in the preoptic area. In addition, NEI might modulate LH secretion by innervating the AVPV. – 
Reproduced from Attademo et al, 2006, with permission from Neuroendocrinology. 
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